Maxymune Therapeutics, Inc.
Biotechnology company · Los Altos, California, United States
Maxymune Therapeutics, Inc. is a biotechnology company headquartered in Los Altos, California, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2026.
Maxymune Therapeutics at a glance
What does Maxymune Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.7 million sold (2026).
Frequently asked questions about Maxymune Therapeutics
Where is Maxymune Therapeutics headquartered?
Maxymune Therapeutics, Inc. is headquartered in Los Altos, California, United States.
What does Maxymune Therapeutics do?
Maxymune Therapeutics, Inc. is a biotechnology company.
When was Maxymune Therapeutics founded?
The earliest incorporation on record for Maxymune Therapeutics, Inc. is in 2023, according to public company registers.
Similar companies
- Quadriga Biosciences, IncLos Altos, California, United States
- Sociometrics CorporationLos Altos, California, United States
- Cardiac RSK3 Inhibitors, LLCLos Altos, California, United States
- Sciogen LLCLos Altos, California, United States
- MultiValent Biotherapies, Inc.Los Altos, California, United States
- Retrotope, Inc.Los Altos, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences